ストックスクリーナーアプリを入手
6.78
2.45%
-0.17
アフターアワーズ：
6.78
前日終値:
$6.95
開ける：
$6.9
24時間の取引高:
315.77K
Relative Volume:
1.15
時価総額：
$257.89M
収益：
$239.40M
当期純損益:
$104.44M
株価収益率:
2.2905
EPS:
2.96
ネットキャッシュフロー:
$-18.50M
1週間 パフォーマンス:
-7.25%
1か月 パフォーマンス:
+13.00%
6か月 パフォーマンス:
-26.54%
1年 パフォーマンス:
-61.48%
1日の値動き範囲:
$6.35
$6.94
1週間の範囲:
$6.35
$7.535
52週間の値動き範囲:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
名前
Entrada Therapeutics Inc
セクター
電話
857-305-1825
住所
ONE DESIGN CENTER PLACE, BOSTON
TRDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
6.78 | 264.36M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-01-05 | 開始されました | Oppenheimer | Outperform |
| 2023-04-03 | 開始されました | H.C. Wainwright | Buy |
Entrada Therapeutics Inc (TRDA) 最新ニュース
How risky is Entrada Therapeutics Inc. stock nowQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Will Entrada Therapeutics Inc. stock gain from strong economy2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Real time pattern detection on Entrada Therapeutics Inc. stockQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Why Entrada Therapeutics Inc. stock is favored by pension fundsLayoff News & Verified Momentum Stock Alerts - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarChart Signals & Reliable Price Action Trade Plans - newser.com
Understanding Entrada Therapeutics Inc.’s price movementPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peersMarket Volume Summary & AI Driven Stock Movement Reports - newser.com
Applying sector rotation models to Entrada Therapeutics Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.CEO Change & Daily Entry Point Alerts - newser.com
Visualizing Entrada Therapeutics Inc. stock with heatmapsProfit Target & Risk Controlled Stock Alerts - newser.com
Applying big data sentiment scoring on Entrada Therapeutics Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Entrada Therapeutics Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Intraday Action & Accurate Trade Setup Notifications - newser.com
Entrada Therapeutics: Undervalued Leader in RNA Therapeutics with Promising DMD Pipeline - TipRanks
Using Python tools to backtest Entrada Therapeutics Inc. strategies2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Entrada Therapeutics (TRDA) Expected to Announce Earnings on Tuesday - MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Analyzing Entrada Therapeutics Inc. with multi timeframe chartsEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Entrada Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Entrada (Nasdaq: TRDA) to present at Jefferies London and Evercore Miami conferences - Stock Titan
Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 7% – What’s Next? - Defense World
Published on: 2025-10-27 16:51:27 - newser.com
Published on: 2025-10-27 06:13:39 - newser.com
Entrada Therapeutics Inc (TRDA) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):